The global demand for Pulmonary Drug Delivery Devices Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.
Pulmonary drug delivery devices are devices used for delivering drug formulation through the mouth by inhalation. The inhaled drug deposits in the lower airways treat pulmonary diseases like bronchial asthma and cystic fibrosis. These devices fall under three different classes, like metered-dose inhalers, nebulizers, and dry powder inhalers. The delivery mechanism chosen depends on the type of drug formulation, the site of action, and the lungs' pathophysiology. Relatively small amounts of molecules are used to deliver substantial drug quantities to the target when using these devices. Smart devices providing real-life objective information about a patient's adherence patterns and their inhaler technique are available.
Market Dynamics
The critical growth inducer for the pulmonary drug delivery devices market is the growing incidences of chronic respiratory disorders like tuberculosis, bronchitis, pneumonia, and asthma. Low efficacy of traditional treatment methods and better penetrability of drugs when using these devices will benefit market growth. Continued research and development to formulate new drugs and innovative delivery mechanisms to ensure minimal dosage will boost the market growth. The rising geriatric population and increased preference for minimally invasive treatment options will be a market booster. Rapid growth in the e-commerce sector will expand the growth of this market. Low drug absorption and enzymatic instability witnessed when using these devices will hinder the development of this market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of pulmonary drug delivery devices.
Market Segmentation
This section of the pulmonary drug delivery devices market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Product
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Accessories
By Application
- Asthma
- Cystic Fibrosis
- COPD
- Allergic Rhinitis
- Others
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- E-Commerce
By End-Use
- Hospitals & Clinics
- Homecare
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Pulmonary Drug Delivery Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Pulmonary Drug Delivery Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pulmonary drug delivery devices market include GlaxoSmithKline plc,Philips Respironics,Boehringer Ingelheim GmbH,Novartis AG,3M Healthcare,GF Health Products, Inc.,Merck & Co., Inc.,AstraZeneca. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . PULMONARY DRUG DELIVERY DEVICES – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Product
3.7.2 By Application
3.7.3 By Distribution Channel
3.7.4 By End-Use
3.7.5 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY PRODUCT
6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Metered Dose Inhalers Market by Regions
6.6 Dry Powder Inhalers Market by Regions
6.5 Nebulizers Market by Regions
6.7 Accessories Market by Regions
7 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Asthma Market by Regions
7.5 Cystic Fibrosis Market by Regions
7.6 COPD Market by Regions
7.7 Allergic Rhinitis Market by Regions
7.8 Others Market by Regions
8 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Retail Pharmacies Market by Regions
8.5 Hospital Pharmacies Market by Regions
8.6 E-Commerce Market by Regions
9 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY END-USE
9.1 Overview by End-Use
9.2 Historical and Forecast Data
9.3 Analysis by End-Use
9.4 Hospitals & Clinics Market by Regions
9.5 Homecare Market by Regions
10 . GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY
10.1. Regional Outlook
10.2. Introduction
10.3. North America
10.3.1. Overview, Historic and Forecast Data
10.3.2. North America By Segment
10.3.3. North America By Country
10.3.4. United State
10.3.5. Canada
10.3.6. Mexico
10.4. Europe
10.4.1. Overview, Historic and Forecast Data
10.4.2. Europe by Segment
10.4.3. Europe by Country
10.4.4. United Kingdom
10.4.5. France
10.4.6. Germany
10.4.7. Italy
10.4.8. Russia
10.4.9. Rest Of Europe
10.5. Asia Pacific
10.5.1. Overview, Historic and Forecast Data
10.5.2. Asia Pacific by Segment
10.5.3. Asia Pacific by Country
10.5.4. China
10.5.5. India
10.5.6. Japan
10.5.7. South Korea
10.5.8. Australia
10.5.9. Rest Of Asia Pacific
10.6. Latin America
10.6.1. Overview, Historic and Forecast Data
10.6.2. Latin America by Segment
10.6.3. Latin America by Country
10.6.4. Brazil
10.6.5. Argentina
10.6.6. Peru
10.6.7. Chile
10.6.8. Rest of Latin America
10.7. Middle East & Africa
10.7.1. Overview, Historic and Forecast Data
10.7.2. Middle East & Africa by Segment
10.7.3. Middle East & Africa by Country
10.7.4. Saudi Arabia
10.7.5. UAE
10.7.6. Israel
10.7.7. South Africa
10.7.8. Rest Of Middle East And Africa
11 . COMPETITIVE LANDSCAPE OF THE PULMONARY DRUG DELIVERY DEVICES COMPANIES
11.1. Pulmonary Drug Delivery Devices Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments
12 . COMPANY PROFILES OF PULMONARY DRUG DELIVERY DEVICES INDUSTRY
12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. GlaxoSmithKline plc
12.3.1. Company Overview
12.3.2. Financials
12.3.3. Products
12.3.4. Recent Developments
12.4. Philips Respironics
12.4.1. Company Overview
12.4.2. Financials
12.4.3. Products
12.4.4. Recent Developments
12.5. Boehringer Ingelheim GmbH
12.5.1. Company Overview
12.5.2. Financials
12.5.3. Products
12.5.4. Recent Developments
12.6. Novartis AG
12.6.1. Company Overview
12.6.2. Financials
12.6.3. Products
12.6.4. Recent Developments
12.7. 3M Healthcare
12.7.1. Company Overview
12.7.2. Financials
12.7.3. Products
12.7.4. Recent Developments
12.8. GF Health Products, Inc.
12.8.1. Company Overview
12.8.2. Financials
12.8.3. Products
12.8.4. Recent Developments
12.9. Merck & Co., Inc.
12.9.1. Company Overview
12.9.2. Financials
12.9.3. Products
12.9.4. Recent Developments
12.10. AstraZeneca
12.10.1. Company Overview
12.10.2. Financials
12.10.3. Products
12.10.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Product (USD MN)
- Metered Dose Inhalers Market by Geography (USD MN)
- Dry Powder Inhalers Market by Geography (USD MN)
- Nebulizers Market by Geography (USD MN)
- Accessories Market by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Asthma Market by Geography (USD MN)
- Cystic Fibrosis Market by Geography (USD MN)
- COPD Market by Geography (USD MN)
- Allergic Rhinitis Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by Distribution Channel (USD MN)
- Retail Pharmacies Market by Geography (USD MN)
- Hospital Pharmacies Market by Geography (USD MN)
- E-Commerce Market by Geography (USD MN)
- Analysis by End-Use (USD MN)
- Hospitals & Clinics Market by Geography (USD MN)
- Homecare Market by Geography (USD MN)
- Global Pulmonary Drug Delivery Devices Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Pulmonary Drug Delivery Devices Report
- Market Research Process
- Market Research Methodology
- Global Pulmonary Drug Delivery Devices Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Distribution Channel
- Market Attractiveness Analysis by End-Use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Product (USD MN)
- Metered Dose Inhalers Market by Geography (USD MN)
- Dry Powder Inhalers Market by Geography (USD MN)
- Nebulizers Market by Geography (USD MN)
- Accessories Market by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Asthma Market by Geography (USD MN)
- Cystic Fibrosis Market by Geography (USD MN)
- COPD Market by Geography (USD MN)
- Allergic Rhinitis Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by Distribution Channel (USD MN)
- Retail Pharmacies Market by Geography (USD MN)
- Hospital Pharmacies Market by Geography (USD MN)
- E-Commerce Market by Geography (USD MN)
- Global Market Analysis by End-Use (USD MN)
- Hospitals & Clinics Market by Geography (USD MN)
- Homecare Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.